Evive Biotechnology (shanghai) Ltd opposition analysis

COMPANY ANALYSIS

Latest patents of Evive Biotechnology (shanghai) Ltd opposed by its competitors

Patent:
Grant Date:
Nov 1, 2023
Title:
Use Of Il-22 Dimer In Manufacture Of A Medicament For Intravenous Administration
Oppositions:
1
Patent:
Grant Date:
Jul 12, 2023
Title:
Methods Of Use For Il-22 In The Treatment Of Gastrointestinal Graft Vs. Host Disease
Oppositions:
1

Competitors of Evive Biotechnology (shanghai) Ltd

STRAWMAN LIMITED

Want to track Evive Biotechnology (shanghai) Ltd?

Feel free to send us a message here and we will get back to you